Transdermal delivery of cyclodextrin-solubilized curcumin

Drug Delivery and Translational Research
Raksha GhanghoriaN K Jain

Abstract

The purpose of the present investigation was to explore the effect of cyclodextrin (CD) as permeation enhancer through rat skin in the form of a valuable and stable transdermal drug delivery system by exploiting its favorable properties. Phase-solubility studies demonstrated that the CD:drug ratio 1:2 was employed in complexation. Solid-state characterizations of complexes was performed by differential scanning calorimetry, X-ray diffractometry, Fourier transform infrared, nuclear magnetic resonance spectrophotometry analysis, and scanning electron micrograph. The HP-β-CD by virtue of its greater stability than the pure curcumin (CMN), allowed greater transdermal flux of CMN indicative of enhanced permeation via CMN-2-hydroxy propyl β cyclodextrins (HP-β-CD). Permeability studies of drug, complex, and with various penetration enhancers (PEs), were performed through rat skin, highlighted a favorable effect of CDs on drug permeation rate, due to its solubilizing action; in contrast with unpredictably poor skin permeation of pure drug. The complexes were found to cause relatively less irritation as compared to the pure drug and drug with PEs in skin irritation studies. The anti-inflammatory activity using paw odema model showed th...Continue Reading

References

Aug 1, 1976·Biochemical Pharmacology·O P Sharma
Nov 1, 1996·Journal of Pharmaceutical Sciences·R A Rajewski, V J Stella
Apr 1, 1997·The Journal of Pharmacy and Pharmacology·M V BentleyJ H Collett
Jun 14, 2000·International Journal of Pharmaceutics·R F LopezM V Bentley
Aug 8, 2001·International Journal of Pharmaceutics·T Loftsson, M Masson
Mar 7, 2002·Journal of Agricultural and Food Chemistry·Ben-Li ZhangMaryvonne L Martin
Jun 13, 2002·Journal of Agricultural and Food Chemistry·Guddadarangavvanahally K JayaprakashaKunnumpurath K Sakariah
Nov 29, 2002·Drug Development and Industrial Pharmacy·Linda A FeltonDonald A Godwin
Sep 5, 2003·International Journal of Pharmaceutics·M M R DiasJ Hadgraft
May 8, 2004·International Journal of Pharmaceutics·R J Babu, J K Pandit
Sep 22, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vaibhav DubeyN K Jain
Jan 30, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jing YangLinda A Felton
Aug 5, 2008·International Journal of Pharmaceutics·Branko J DrakulićMire Zloh
Jan 23, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Wei YangRobert O Williams
May 4, 2010·International Journal of Pharmaceutics·Victoria KlangClaudia Valenta
Nov 9, 2010·International Journal of Pharmaceutics·Francesca UngaroMaria Immacolata La Rotonda

❮ Previous
Next ❯

Citations

Jul 29, 2017·Advanced Materials·Rong YangDaniel S Kohane
Sep 7, 2018·Drug Development Research·Shery Jacob, Anroop B Nair
Jan 31, 2020·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Duong T T PhamThao T D Tran
Mar 12, 2021·Journal of Biomaterials Science. Polymer Edition·Ashish Kumar GargPrashant Kesharwani
Sep 10, 2021·International Journal of Pharmaceutics·Suman GyanewaliSushama Talegaonkar

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Pharmaceutical Development and Technology
Nikunjana A PatelRakesh P Patel
AAPS PharmSciTech
Lucas ChierentinHérida Regina Nunes Salgado
Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences
Mario JugBiserka Cetina-Cizmek
© 2021 Meta ULC. All rights reserved